Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Assessment of Ulcerative Colitis Patients with Elevated Neutrophilic Infiltration in the Colonic Mucosal Epithelium Using Komagane Subclassification of Geboes Score Grade 3

View through CrossRef
(1) Background: Interleukin (IL)-23 exerts its effects by activating Th17 cells, resulting in high neutrophilic infiltration in the colonic mucosal epithelium. We have developed a scoring method for refining Geboes score Grade 3 to identify active ulcerative colitis (UC) patients with high epithelial neutrophilic infiltration (Geboes Grade 3.2 or 3.3). (2) Methods: Colonoscopy and histology findings were assessed using the Mayo Endoscopic Subscore (MES) and Geboes Grade 3. The percentage of crypts with neutrophilic infiltration, calculated as the number of crypts with neutrophilic infiltration/total crypts in a glass slide, was used to subclassify Geboes score Grade 3 into Grades 3.0, 3.1, 3.2 and 3.3. (3) Results: This scoring method was then applied to 30 enrolled patients (20 males; median age 46 years), yielding a distribution of Geboes Grade 3.0 in 6 (20%), 3.1 in 7 (23%), 3.2 in 16 (53%) and 3.3 in 1 (3%) patient(s). Of the 18 UC patients with MES 2, 5 (28%) had Grade 3.1 and 12 (67%) had Grade 3.2. (4) Conclusions: we have developed a novel Geboes score Grade 3 scoring method and applied it to 30 patients: approximately 60% had Grade 3.2 or higher. This method may help to identify UC patients likely to respond effectively to IL-23 antagonists.
Title: Assessment of Ulcerative Colitis Patients with Elevated Neutrophilic Infiltration in the Colonic Mucosal Epithelium Using Komagane Subclassification of Geboes Score Grade 3
Description:
(1) Background: Interleukin (IL)-23 exerts its effects by activating Th17 cells, resulting in high neutrophilic infiltration in the colonic mucosal epithelium.
We have developed a scoring method for refining Geboes score Grade 3 to identify active ulcerative colitis (UC) patients with high epithelial neutrophilic infiltration (Geboes Grade 3.
2 or 3.
3).
(2) Methods: Colonoscopy and histology findings were assessed using the Mayo Endoscopic Subscore (MES) and Geboes Grade 3.
The percentage of crypts with neutrophilic infiltration, calculated as the number of crypts with neutrophilic infiltration/total crypts in a glass slide, was used to subclassify Geboes score Grade 3 into Grades 3.
0, 3.
1, 3.
2 and 3.
3.
(3) Results: This scoring method was then applied to 30 enrolled patients (20 males; median age 46 years), yielding a distribution of Geboes Grade 3.
0 in 6 (20%), 3.
1 in 7 (23%), 3.
2 in 16 (53%) and 3.
3 in 1 (3%) patient(s).
Of the 18 UC patients with MES 2, 5 (28%) had Grade 3.
1 and 12 (67%) had Grade 3.
2.
(4) Conclusions: we have developed a novel Geboes score Grade 3 scoring method and applied it to 30 patients: approximately 60% had Grade 3.
2 or higher.
This method may help to identify UC patients likely to respond effectively to IL-23 antagonists.

Related Results

Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis
Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis
Background: The growing number of ulcerative colitis (UC) treatments has complicated the selection process. We hypothesized that the degree of epithelial neutrophilic infiltration,...
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Background: Ulcerative colitis is a chronic idiopathic inflammatory bowel disease (IBD) characterized by intestinal inflammation confined to the superficial mucosal layer. Mesalazi...
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Ulcerative colitis is a multifactorial, chronic inflammatory disease of the bowel that can cause physical, social and emotional injury to the patient. While perhaps not always maki...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Pharmacological correction of ulcerative colitis with dalargin
Pharmacological correction of ulcerative colitis with dalargin
Introduction: Ulcerative colitis is a chronic colonic disease with frequent relapses, affecting mainly people of active age. The effectiveness of existing treatment methods remains...
Histopathological predictor of response to mirikizumab in active ulcerative colitis
Histopathological predictor of response to mirikizumab in active ulcerative colitis
Abstract This case series reports three patients with active ulcerative colitis (UC) successfully treated with mirikizumab, a selective IL-23p19 monoclonal antibo...

Back to Top